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Superficial Siderosis
A Potential Diagnostic Marker of Cerebral Amyloid
Angiopathy in Alzheimer Disease
Howard H. Feldman, MD; Luis F. Maia, MD; Ian R.A. Mackenzie, MD;
Bruce B. Forster, MD; Jeff Martzke, PhD; Andrew Woolfenden, MD
Background and Purpose—Superficial siderosis of the central nervous system results from chronic bleeding in the
superficial layers of the cortex and spinal cord. In cerebral amyloid angiopathy (CAA), there is amyloid deposition in
meningeal and meningo-cortical arteries and capillaries, predisposing them to rupture. CAA is frequently associated
with Alzheimer disease (AD).
Methods and Results—We report a series of 3 AD patients with MRI evidence of superficial siderosis. Two had
neuropathological examination confirming superficial siderosis, AD, and CAA.
Conclusions—Superficial siderosis should be recognized within the spectrum of AD with CAA and considered as a
possible antemortem diagnostic feature. (Stroke. 2008;39:2894-2897.)
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Superficial siderosis of the central nervous system (SS-CNS)is an uncommon condition in which hemosiderin deposits in
the subpial layers of the brain, spinal cord, and cranial nerves.
SS-CNS can result from repeated or chronic bleeding in the
subarachnoid space because of hemorrhagic tumors, trauma,
vascular malformations/aneurysms, or transthyretin meningov-
ascular amyloidosis.1,2 It can be detected with gradient-recalled
echo MRI with T2* weighting that demonstrates bleeding with
low signal from deposited iron products.1,2 The most common
clinical syndrome of SS-CNS includes sensorineural hearing
loss, cerebellar ataxia, and pyramidal signs.1 SS-CNS has not
been clearly associated previously with either cerebral amyloid
angiopathy (CAA) or Alzheimer disease (AD).1,3 CAA is de-
fined by amyloid deposition in the media of vessels within
arteries and arterioles of the cortex and leptomeninges.4 Al-
though CAA can be age-related in individuals without dementia,
it has an estimated prevalence of 80% to 100% in patients with
AD.5 The in vivo diagnosis of CAA is limited, based on
radiological or biopsy features.6 Gradient-recalled echo MRI
with T2* weighting demonstrating chronic parenchymal cortical
microhemorrhages supports the diagnosis of CAA.6 In AD-
related CAA, there is usually prominent involvement of the most
superficial vessels of the brain; however, subpial/subarachnoid
hemorrhage or SS have not been previously reported with it.7
Subjects and Methods
We describe a case series of 3 patients from the University of British
Columbia Clinic for Alzheimer Disease & Related Disorders. These
patients had clinical, cognitive, and neuroimaging assessments
(Table, Figure 1). The neuropathology of 2 patients are presented in
Figure 2.
Case 1
Case 1 is a 60-year-old right-hand-dominant man who presented with
6 months of progressive aphasia. He had mild psychobehavioral
changes. The results of his neurological examination were normal,
whereas cognitively he had severe nonfluent aphasia with relative
sparing of episodic memory. Laboratory work-up for coagulopathy
was negative and noninvasive stroke work-up (carotid duplex,
echocardiogram, and Holter monitor) was normal. Cerebrospinal
fluid was slightly blood-tinged with 450 red blood cells (106), 2
white blood cells (106), and normal protein. His condition declined
progressively in the subsequent 2 years before experiencing several
20-minute episodes of right facial and arm numbness, without
change in speech or language. Gradient-recalled echo MRI showed
left hemispheral gyriform low-signal pattern. (Figure 1A). Cerebral
angiography was normal. He died 3 years after first assessment from
a left parietal cortical hemorrhage. Autopsy examination demon-
strated neuritic senile plaques, neurofibrillary tangles, and neuropil
threads of sufficient number and distribution to fulfill NIA/Reagan
criteria for definite AD. Many cortical and leptomeningeal vessel
walls were thickened by amyloid deposition (Figure 2A). There were
moderate numbers of small, focal, cortical defects characterized by
reactive astrocytes and hemosiderin-laden macrophages, consistent
with chronic microscopic hemorrhages or hemorrhagic infarcts.
There was more diffuse accumulation of hemosiderin within macro-
phages in the subarachnoid space and superficial cortex (Figure 2B).
The neuropathological diagnosis was AD and CAA associated with
SS. The number, size, and distribution of microscopic infarcts and
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hemorrhages were not sufficient enough to warrant a separate
diagnosis of vascular dementia.
Case 2
Case 2 is a 65-year-old, right-hand-dominant man who presented
with a 6-year history of dementia with progressive aphasia. His
neurological examination results were normal, whereas cognitively
he had bihemispheral impairment, with language being the most
impaired (Table). MRI demonstrated a small, left, occipital cortical
infarct, whereas spin-echo T2-weighted images showed gyriform left
hemispheral low signal (Figure 1B). Noninvasive stroke work-up
was normal. Laboratory studies excluded coagulopathy. Autoim-
mune serology was negative. His condition declined steeply over 18
months, with progressively disabling gait apraxia developing. Au-
topsy examination demonstrated severe senile plaque and neurofi-
brillary tangle pathology, fulfilling NIA/Reagan criteria for definite
AD. Small, chronic, cortical infarcts were present in both occipital
lobes and cerebellar hemispheres. Histological definite AD was
confirmed by NIA/Reagan criteria. There was severe CAA affecting
cortical and leptomeningeal vessels (Figure 2C). Neocortical regions
showed focal collections of hemosiderin-laden macrophages around
congophilic vessels and in the subpial region (SS), most extensively
over the left frontal lobe (Figure 2D). There was moderately severe
arteriolosclerosis of the basal ganglia but no lacunar infarcts.
Neuropathological diagnosis was AD and CAA with SS and cere-
brovascular disease. The location of the chronic infarcts made it
unlikely that they contributed to the patient’s dementia.
Case 3
Case 3 is a 69-year-old right-hand-dominant woman who presented with
2 years of progressive cognitive decline. Her neurological examination
results were normal, whereas cognitively she demonstrated prominent
aphasia and mild episodic memory impairment (Table). CT showed a
4-mm aneurysm of the right anterior cerebral artery. Medications
included acetylsalicylic acid (ASA), Ginkgo biloba, and donepezil. Her
Table. Clinical, Neuropsychological, and Neuroradiological Features of CAA-Related Meningeal Siderosis Patients
Presenting Features
MR T2* or T2WI
Patient N/Age/Sex
Cognitive Severity
Cognitive DomainsMMS 3-MS Gyriform Hyposignal, Location Cortical Microbleeds, N
1/60/M 23 83 Language* Left frontal* 2 (left and right frontal lobe)
Short-term memory‡ Left parietal*
Visuospatial processing§ Left temporal*
Praxis§ Right frontal‡
Executive function§ Right parietal§
Right temporal§
2/59/M 21 52 Language* Left frontal lobe* NA
Short-term memory‡ Left parietal†
Visuospatial processing‡ Left temporal‡
Praxis‡ Right frontal§
Executive function† Right parietal§
Right temporal§
3/69/F 22 71 Language† Left frontal† 1 (right frontal lobe)
Short-term memory‡ Left parietal*
Visuospatial processing‡ Left temporal‡
Praxis§ Right frontal†
Executive function‡ Right parietal§
Right temporal§
*Severely affected.
†Moderately affected.
‡Mildly affected.
§Not affected.
F indicates female; L, left; M, male; NA, not available; R, right.
Figure 1. Gyriform low signal (arrowheads),
corresponding to meningeal siderosis, in the
frontal cortex bilaterally and left parietal cortex
(A), gradient-recalled echo MRI (patient 1). Gyri-
form low signal (arrowheads) in the left frontal
cortex (B), T2-MRI (patient 2). Gyriform low sig-
nal (arrowheads) in the left parietal cortex (C),
gradient-recalled echo MRI (patient 3).
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condition declined progressively over the next 18 months without
stroke-like episodes. However, on follow-up neuroimaging, she had a
new serpiginous right frontal lesion, which was confirmed by MRI to be
a subacute cerebral hemorrhage. T2*-weighted gradient-recalled echo
showed gyriform low signal over the left parietal lobe (Figure 1C). Her
aneurysm was unchanged without low signal in the wall or adjacent
interhemispheric regions. Screening for coagulopathy was negative. AD
and SS, presumed to be CAA-related, were diagnosed clinically given
her course and presentation without neuropathological confirmation.
ASA and Ginkgo biloba were discontinued.
Discussion
We report a series of 3 AD patients with CAA-related SS.
Each MRI showed SS, whereas the 2 available autopsies
confirmed the diagnoses of AD, CAA, and SS. The clinical
features and course of each patient had aspects that were
atypical for AD. The first patient had a severe nonfluent
aphasia before recurrent transient neurological spells devel-
oped. The second patient had an unusually prominent pro-
gressive aphasia for his otherwise mild-severity AD with
dominant-hemisphere SS. The third patient also had promi-
nent aphasia greater than impaired episodic memory. We
postulate that these features that are atypical for AD were
related to the presence of AD, CAA, and SS.8 Unlike patients
with “classical” SS,1,3 these patients did not present any
cerebellar or brain stem signs.
The presence of SS documents previous hemorrhage. The
exact origin of the bleeding to produce this SS is not known.
We suspect it either spread from superficial neocortical
hemorrhage into the subarachnoid space or leaked through
arteriolar/arterial vessels within the subarachnoid space, or
both.1 The remote possibility of a spinal arteriovenous mal-
formation (AVM) in each of these 3 patients was not formally
excluded. Primary subarachnoid or subpial hemorrhage re-
lated to CAA has been described concomitantly with intra-
parenchymal hemorrhages, whereas in a few reports sporadic
CAA cases have been associated with primary subarachnoid
hemorrhage, presenting with transient neurological symp-
toms.9,10 These are the first cases to our knowledge of
neuropathologically confirmed CAA in AD with SS. The
relation between amyloid deposition, subarachnoid hemor-
rhage, and SS is not exclusive to sporadic A-related CAA.
Transthyretin meningovascular amyloidosis has also been
reported to have transient neurological symptoms attributed
to ischemia or microhemorrhage.2,11
Although we might speculate about the potential clinical–
radiological correlation between the prominent aphasias and
the left hemispheral SS, we are limited by our small number
of cases and the potential for selection bias. Further studies
are needed to determine the prevalence of SS in AD and CAA
and its clinical relevance in cognitive decline and focal
neurological signs.
These cases illustrate that SS can be the important indicator
of CAA in AD beyond the cortical microhemorrhages or
lobar hemorrhages that are more readily recognized as being
CAA-related. These cases reinforce the usefulness of MRI
gradient-recalled echo in detecting CAA-related hemosiderin
deposits, not only intraparenchymal6 but also at the subpial–
subarachnoid level, particularly when intraparenchymal hem-
orrhages are not detected or observed. When present, SS may
support the antemortem diagnosis of concomitant CAA in
AD, and it may be associated with clinical features, including
those that are atypical for AD.
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Figure 2. Leptomeningeal and cortical vessels
showing severe CAA with A- (A), immunohis-
tochemistry staining (patient 1). Hemosiderin
deposition within macrophages in the sub-
arachnoid space (arrow) and within superficial
cortex (arrowheads) (B), Pearl’s blue iron stain-
ing (patient 1). Amyloid demonstrating vessel-
within-vessel pattern (arrow) (C), Congo red
stain (patient 2). Hemosiderin deposition (D)
within leptomeningeal macrophages (arrow)
and within macrophages in superficial neocor-
tex (arrowheads), Pearl’s blue iron staining
(patient 2).
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illustrative MRI of one of the cases discussed in more detail in this
current article.
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